Could a common cholesterol medication also help lupus symptoms?
If you have lupus and you're already taking a statin for cholesterol or heart protection, there may be an additional benefit worth knowing about. Statins are a class of medication used to lower cholesterol and reduce the risk of heart attack and stroke; they include common drugs like Lipitor and Crestor.
A new meta-analysis published in February 2026 found that statin use is associated with reduced disease activity and lower markers of inflammation in people with systemic lupus erythematosus (SLE), with the most notable effects seen in patients younger than 40. The analysis pooled data from 12 studies across 3,596 records, evaluating disease activity scores (SLEDAI), C-reactive protein (CRP), interleukin-6 (IL-6), and erythrocyte sedimentation rate (ESR)—all key measures of inflammation and disease burden in SLE.
The findings were most consistent for inflammation markers. Statin use was associated with lower CRP levels across all study types. After eliminating outliers and studies with different research methods, the main findings also showed statins to be associated with significant reductions in both IL-6 and ESR levels. Moreover, patients reported reduced lupus disease activity in controlled before–after studies, and the improvements were most evident in patients under the age of 40.
It's worth noting that the overall effect is described as modest, and results on disease activity were not consistent across all study types. Researchers call for further studies before statins are considered a primary tool for managing lupus activity. Still, given that people with lupus already face elevated cardiovascular risk, the possibility that statins may offer additional anti-inflammatory benefits is meaningful to patients.
Tracking medication use across large patient populations is how findings like these get stronger over time. With more data, we can more reliably see whether certain medications improve symptoms for autoimmune disease patients. To add your data to our registry, take our Treatment and Care Surveys, which are available to retake every 6 months.
We've also invited John Muller from Getting Up to join us next week for our Monthly Webinar. John will be sharing his insights on the fundraising process and the operations of Getting Up.
Details: Thursday, April 16, 2026, from 12:00 to 1:00 PM EST
Agenda:
12:00 - 12:05 PM: Convene
12:05 - 12:10 PM: Introductions
12:10 - 12:40 PM: GettingUp.Org, A Volunteer-Powered Model for Rare Disease Impact
12:40 - 1:00 PM: Q&A
To support the Autoimmune Registry, please share our information with others who have autoimmune diseases. Donations are also greatly appreciated!
